Thomas Okray
Analyst · Williams Blair. Your line is now alive
Thanks DG. Looking at our total company adjusted results for the quarter daily sales were up 2.5%, volume grew 2.5% and both price and the impact of FX were flat to the prior year. Two of our businesses, AGI and Cromwell are not only facing challenging end markets but are also in the middle of turnarounds. Their results are adversely impacting the company's performance. For perspective the U S segment and endless assortment. businesses combined were up 4.5% in the quarter and 5% year-to-date versus the prior year. Moving to gross profit. Our total company gross profit margin declined 80 basis points versus the prior year. The decline in gross profit margin was driven primarily by the timing of U.S. price adjustments during the year, which resulted in negative price cost spread in the U.S in the third quarter. Lower gross profit margin of our endless assortment businesses also contributed to the decline. Year-to-date, our total company gross profit margin is down 40 basis points versus the prior year. For the fourth quarter, we expect the company's gross profit margin to be higher than the third quarter. We drove operating earnings growth of 2% in the quarter. Our operating margin, however, declined 20 basis points versus the prior year due primarily to the investments we're making to drive growth at Zoro. Excluding the investments in Zoro, SG&A leverage completely offset the gross profit margin decline in the quarter. As expected, SG&A grew at half the rate of sales. As an organization, we will continue to rigorously manage expenses while ensuring we're providing the absolute best experience for our customers. Year-to-date, operating margin has expanded 30 basis points and we've driven incremental margin of 26%. We were also focused on generating strong cash flow while operating cash flow in the quarter decreased 8% driven primarily by unfavorable timing of supplier payments, operating cash flow was up 3.5% year-to-date and close to a 100% of reported net income. Year-to-date, we've returned $842 million to shareholders through $242 million in dividends and $600 million in share buybacks. We expect to continue to buyback shares in the fourth quarter. Now, let's turn to our performance in the U.S. The demand environment has slowed throughout the year and the market was flat in the third quarter. Daily sales were up 2.5% comprised of volume growth of 2.5%, flat price inflation, 0.5% increase of inter company sales to Zoro and a 0.5% decline in specialty brands. In the quarter, we grew 250 basis points faster than the market driven by strong execution of our U.S. growth initiative. U.S. gross profit margin declined 80 basis points in the quarter versus the prior year driven primarily by product cost inflation outpacing price inflation partially offset by favorability and supply chain. At the beginning of 2019, we wanted to ensure that our pricing was sufficient to cover product cost increases related to tariffs and general inflation. In retrospect, we were a little too aggressive. To ensure that our pricing was market-based, we dialed pricing back in the second quarter, while third quarter gross profit margin was a little below our expectations, we estimate that gross profit margin will be higher in the fourth quarter and the third quarter and the results for the entire year will be consistent with the expectations set at the start of the year. In an environment with uncertainty around tariffs and market demand, quarterly noise is common place. Year-to-date picture is often more useful on the evaluating performance. More perspective on a year-to-date basis excluding the write down of remaining contract negotiations, our price cost spread is favorable. Further, we continue to effectively manage product cost inflation related to both tariffs and general inflation. In the quarter both improved sequentially and we expect that trend to continue in the fourth quarter. U.S operating earnings increased 4% in the quarter, U S operating margin was flat versus the prior year as lower gross profit margin was completely offset by SG&A leverage. SG&A was flat on sales growth of 4%. In Canada, daily sales declined 14.5% on a constant currency basis. Price inflation was 1% in the quarter and volume declined 15.5%. Volume remains the main issue in Canada. While optimization of the cost structure is strong, it's taking time for us to stabilize top-line performance. Operating margin was positive in the third quarter for the first time in 2019 driven by improvement to gross profit margin and continued diligence on the SG&A line. Gross profit margin improved 50 basis points versus the prior year largely due to supply chain efficiencies, offsetting negative price cost spread. Moving to other businesses, which includes our endless assortment model and our international portfolio. Daily sales were up 9% in the third quarter on a constant currency basis due to revenue growth from our endless assortment model. Together MonotaRO and Zoro daily sales grew 19.5% in the quarter. Gross profit margin for the other businesses declined 130 basis points driven by promotional activities at Zoro and freight headwinds at both Zora and MonotaRO. Operating margin declined 220 basis points for the other businesses, primarily driven by long-term growth investments in Zoro U.S. and performance at Cromwell. As we've mentioned in the past, the Cromwell business is facing operational challenges while also experiencing a difficult economic climate. The business is taking action to improve service and the customer experience to drive top-line growth while also improving the cost structure. Page 14 covers our guidance for 2019. At the total company level, we are reiterating all of our guided metrics. At the segment level, we expect the U.S. segment and other businesses to be within their guided ranges. For AGI, we now expect to finish the year below the guided range. Now I'll turn it back to DG for closing remarks.